Detail Information of Exogenous Modulation
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0445 Transporter Info | ||||
Gene Name | SLC6A13 | ||||
Transporter Name | Sodium- and chloride-dependent GABA transporter 2 | ||||
Gene ID | |||||
UniProt ID | |||||
Exogenous factors (drugs, dietary constituents, etc.) Modulation of This DT (EGM) | |||||
---|---|---|---|---|---|
Approved Drug |
|||||
Arsenic |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Arsenic affects the expression of SLC6A13 | [1] | |||
Cisplatin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Cisplatin inhibits the expression of SLC6A13 | [2] | |||
Testosterone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Testosterone increases the expression of SLC6A13 | [4] | |||
Drug Marketed but not Approved by US FDA |
|||||
Rotenone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Rotenone inhibits the expression of SLC6A13 | [3] | |||
Drug in Phase 3 Trial |
|||||
Triclosan |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Triclosan increases the expression of SLC6A13 | [8] | |||
Investigative Drug |
|||||
SNAP-5114 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
SNAP-5114 inhibits the activity of SLC6A13 | [11] | |||
Natural Product |
|||||
Methyleugenol |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Methyleugenol inhibits the expression of SLC6A13 | [9] | |||
Tobacco Smoke Pollution |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Tobacco Smoke Pollution increases the expression of SLC6A13 | [10] | |||
Traditional Medicine |
|||||
Jinfukang |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Jinfukang inhibits the expression of SLC6A13 | [2] | |||
Mycotoxins |
|||||
Aflatoxin B1 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Aflatoxin B1 inhibits the expression of SLC6A13 | [5] | |||
Carcinogen |
|||||
Ethyl Methanesulfonate |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Ethyl Methanesulfonate increases the expression of SLC6A13 | [6] | |||
Benzo(a)pyrene |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Benzo(a)pyrene inhibits the expression of SLC6A13 | [9] | |||
Nanoparticle |
|||||
Silver nanoparticle |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Silver nanoparticle increases the expression of SLC6A13 | [7] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.